Recap: Atossa Therapeutics Q2 Earnings
Atossa Therapeutics (NASDAQ:ATOS) reported its Q2 earnings results on Monday, August 8, 2022 at 04:30 PM.
Here's what investors need to know about the announcement.
Atossa Therapeutics Announces Dosing Completed In Part C of Atossa’s Phase 1/2a Study Of AT-H201 In Healthy Volunteers
Atossa Therapeutics, Inc. (NASDAQ:ATOS) a clinical stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases with a current
20 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
Cyren Ltd. (NASDAQ: CYRN) rose 31.1% to $2.32 in pre-market trading after the company entered into an agreement with Content Services Group to sell all equity interests in its legacy secure email gateway business.
62 Biggest Movers From Yesterday
Gainers
Tenon Medical, Inc. (NASDAQ: TNON) rose 350% to clsoe at $22.50 on Wednesday after the company priced its IPO at $5.00 per share.
Atossa Therapeutics Announces Completion Of Part B Of Clinical Study Of AT-H201
Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases with a current
Atossa Therapeutics Announces Issuance Of Key U.S. Patent Covering Endoxifen
Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative medicines in oncology and infectious disease with a current focus on breast cancer and COVID-19, today
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
ContraFect (NASDAQ:CFRX) stock moved upwards by 4.9% to $2.76 during Friday's after-market session. The company's market cap stands at $108.5 million.
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
ContraFect (NASDAQ:CFRX) stock increased by 4.9% to $2.76 during Thursday's after-market session. The company's market cap stands at $108.5 million.